Russell Barrans, Chief Commercial Officer at Evofem Biosciences, Inc. (EVFM), bought 18,180 shares at $1.14 ($21K) on 2021-06-11, disclosed to the SEC on 2021-06-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| EVFM | SELL | 2020-01-21 | $10K | — | Filing → |
| EVFM | BUY | 2018-11-26 | $990 | — | Filing → |
| EVFM | BUY | 2018-08-13 | $7K | — | Filing → |